J. Am. Chem. Soc. 1999, 121, 593-594
Asymmetric Synthesis of Chiral, Nonracemic
593
Trifluoromethyl-Substituted Piperidines and
Decahydroquinolines
Jinlong Jiang,*,‡ Robert J. DeVita,‡ George A. Doss,†
Mark T. Goulet,‡ and Matthew J. Wyvratt‡
Figure 1.
Department of Medicinal Chemistry
Department of Drug Metabolism
Merck Research Laboratories, Rahway, New Jersey 07065
Scheme 1
ReceiVed September 23, 1998
The synthesis of trifluoromethyl-substituted heterocycles has
become an important area of pharmaceutical research owing to
the unique physical and biological properties imparted by the
trifluoromethyl group.1 In many systems, the substitution of a
methyl by a trifluoromethyl group results in added metabolic
stability and lipophilicity (πCF ) 1.07 vs πCH ) 0.5)2, which
3
3
may improve pharmacokinetic properties of drug candidates.
Although trifluoromethyl derivatives of aromatic nitrogen het-
erocycles are well documented, saturated analogues are much less
known.3 The synthesis of structurally complex trifluoromethyl-
substituted saturated heterocycles in either racemic or enantio-
merically pure forms creates significant challenges for the
synthetic chemist. In this communication, we describe an efficient
preparation of chiral, nonracemic trifluoromethyl-substituted
piperidines and decahydroquinolines from the chiral trifluoro-
methyl lactam 2 via palladium-catalyzed reactions of the R-(tri-
fluoromethanesulfonyloxy)enamine 3 (enamine triflate) and
R-(diphenylphosphoryloxy)enamine 4 (enamine phosphate), as
well as highly regioselective and facially selective Diels-Alder
reactions of the novel, nonracemic trifluoromethyl-substituted
diene 16 (Scheme 3).
Chiral lactams of type 1 (Figure 1) have been extensively
studied as templates in asymmetric syntheses mainly based on
the initial alkylation of the methylene group adjacent to the
carbonyl group either by treatment with a base followed by
reaction with an alkyl halide4a-c or by thio-Claisen rearrangement
of the corresponding thiolactams.5 Synthetic methods for the
introduction of an alkyl group at the position where the lactam
carbonyl group is situated (the 2-position of the six-membered
ring) seldom have been reported.6,7 We now report a cyclic
enamine triflate or phospate route to functionalize the carbonyl
group of the lactam 2.
derived triflates invariably had a stabilizing carbonyl or sulfonyl
group on the lactam-nitrogen atom. Cyclic enamine triflates
without a carbonyl or sulfonyl group on the nitrogen atom and
cyclic enamine phosphates were not previously reported. We now
disclose the preparation of chiral, nonracemic trifluoromethyl-
substituted enamine triflate 3 and enamine phosphate 4 from the
lactam 2, and the preliminary results of their Pd-catalyzed
coupling reactions. The synthetic utility of the intermediates 3
and 4 is illustrated by the first asymmetric synthesis of an
enantiomerically pure 2-trifluoromethyl-6-alkylpiperidine 15, ox-
azoline-protected piperidines 12-14 (Scheme 2), and 2-trifluo-
romethyldecahydroquinolines 20 and 22 (Scheme 3).
Lactam 2 was prepared by condensation of acid 53 with (S)-
(+)-phenylglycinol 6 in the presence of p-toluenesulfonic acid
with a Dean-Stark trap. Purification by column chromatography
afforded a single diastereomer 2 in 70% yield (Scheme 1).
Treatment of the lactam 2 with potassium bis(trimethylsilyl)amide
(KHMDS) at -78 °C followed by reaction with N-(5-chloro-2-
pyridinyl)triflimide (7) gave triflate 3 in 91% yield. Triflate 3 is
stable under basic conditions and was purified by filtration through
a basic aluminum oxide pad, but it was readily hydrolyzed under
acidic conditions. The new triflate 3 was subjected to the typical
organometallic coupling reactions as previously reported for
R-(trifluoromethanesulfonyloxy)encarbamates.8a,b Reaction of the
triflate 3 with methyl cuprate and palladium-catalyzed coupling
reactions with propargyl alcohol, phenylzinc chloride, and carbon
monoxide/methanol gave enamines 8-11 in good to excellent
yield.
Palladium-catalyzed coupling reactions of the lactam-derived
triflates,8a-c and lactone-derived cyclic ketene acetal phosphates9
were reported only recently. All previously reported lactam-
‡ Department of Medicinal Chemistry.
† Department of Drug Metabolism.
(1) (a) Welch, J. T. Tetrahedron, 1987, 43, 3123-3197. (b) Welch, J. T.;
Eswarakrishnan S. Fluorine in Bioorganic Chemistry; John Wiley & Son:
New York, 1991. (c) McAtee, J. J.; Schinazi, R. F.; Liotta, D. C. J. Org.
Chem. 1998, 63, 2161-2167 and references therein.
(2) Arnone, A.; Bernardi, R.; Blasco, F.; Cardillo, R.; Resnati, G.; Gerus,
I. I.; Kukhar, V. P. Tetrahedron 1998, 54, 2809-2818.
(3) Okano, T.; Sakaida, T.; Eguchi, S. J. Org. Chem. 1996, 61, 8826-
8830 and references therein.
(4) (a) Romo, D.; Meyers, A. I. Tetrahedron 1991, 47, 9503-9569. (b)
Meyers, A. I.; Seefeld, M. A.; Lefker, B. A. J. Org. Chem. 1996, 61, 5712-
5713. (c) Meyers, A. I.; Seefeld, M. A.; Lefker, B. A.; Blake, J. F.; Williard,
P. G. J. Am. Chem. Soc. 1998, 120, 7429-7438.
(5) Devine, P.; Meyers, A. I. J. Am. Chem. Soc. 1994, 116, 2633-2634.
(6) Meyers et al.7 recently reported the synthesis of chiral, nonracemic
piperidines from the chiral lactam 1 (n ) 2) via Eschenmoser sulfide
contraction followed by hydrogenation of the ester. Our attempts to use this
method for the synthesis of chiral 2-trifluoromethyl-6-alkylpiperidines were,
however, unsuccessful. Treatment of the CF3 version of chiral thiolactam
derived from 2 with an excess of methyl R-bromoacetate led exclusively to
the recovery of lactam 2 propbably via hydrolysis of a labile thioiminium
intermediate.
Cleavage of the oxazoline ring of oxazoline-protected piper-
idines such as 12 (Scheme 2) by hydrogenation to generate cis-
(8) (a) Foti, C. J.; Comins, D. L. J. Org. Chem. 1995, 60, 2656-2657. (b)
Luker, T.; Hiemstra, H.; Speckamp, W. N. J. Org. Chem. 1997, 62, 8131-
8140. (c) Luker, T.; Hiemstra, H.; Speckamp, W. N. J. Org. Chem. 1997, 62,
3592-3596.
(9) Nicolaou, K. C.; Shi, G.-Q.; Ga¨rtner, G. P.; Yang, Z. J. Am. Chem.
Soc. 1997, 119, 5467-5468.
(7) Munchhof, M. J.; Meyers, A. I. J. Am. Chem. Soc. 1995, 117, 5399-
5400.
10.1021/ja983389n CCC: $18.00 © 1999 American Chemical Society
Published on Web 01/06/1999